Manon Ragonnet-Cronin1, Yunyin W Hu2, Sheldon R Morris3, Zhijuan Sheng2, Kathleen Poortinga2, Joel O Wertheim3. 1. Department of Medicine, University of California, San Diego, CA, USA; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK. Electronic address: manonragonnet@imperial.ac.uk. 2. Division of HIV and STD Programs, Department of Public Health, Los Angeles, CA, USA. 3. Department of Medicine, University of California, San Diego, CA, USA.
Abstract
BACKGROUND: Transgender women are among the groups at highest risk for HIV infection, with a prevalence of 27·7% in the USA; and despite this known high risk, undiagnosed infection is common in this population. We set out to identify transgender women and their partners in a molecular transmission network to prioritise public health activities. METHODS: Since 2006, HIV protease and reverse transcriptase gene (pol) sequences from drug resistance testing have been reported to the Los Angeles County Department of Public Health and linked to demographic data, gender, and HIV transmission risk factor data for each case in the enhanced HIV/AIDS Reporting System. We reconstructed a molecular transmission network by use of HIV-TRAnsmission Cluster Engine (with a pairwise genetic distance threshold of 0·015 substitutions per site) from the earliest pol sequences from 22 398 unique individuals, including 412 (2%) self-identified transgender women. We examined the possible predictors of clustering with multivariate logistic regression. We characterised the genetically linked partners of transgender women and calculated assortativity (the tendency for people to link to other people with the same attributes) for each transmission risk group. FINDINGS: 8133 (36·3%) of 22 398 individuals clustered in the network across 1722 molecular transmission clusters. Transgender women who indicated a sexual risk factor clustered at the highest frequency in the network, with 147 (43%) of 345 being linked to at least one other person (adjusted odds ratio [aOR] 2·0, p=0·0002). Transgender women were assortative in the network (assortativity 0·06, p<0·001), indicating that they tended to link to other transgender women. Transgender women were more likely than expected to link to other transgender women (OR 4·65, p<0·001) and cisgender men who did not identify as men who have sex with men (MSM; OR 1·53, p<0·001). Transgender women were less likely than expected to link to MSM (OR 0·75, p<0·001), despite the high prevalence of HIV among MSM. Transgender women were distributed across 126 clusters, and cisgender individuals linked to one transgender woman were 9·2 times more likely to link to a second transgender woman than other individuals in the surveillance database. Reconstruction of the transmission network is limited by sample availability, but sequences were available for more than 40% of diagnoses. INTERPRETATION: Clustering of transgender women and the observed tendency for linkage with cisgender men who did not identify as MSM, shows the potential to use molecular epidemiology both to identify clusters that are likely to include undiagnosed transgender women with HIV and to improve the targeting of public health prevention and treatment services to transgender women. FUNDING: California HIV and AIDS Research Program and National Institutes of Health-National Institute of Allergy and Infectious Diseases.
BACKGROUND: Transgender women are among the groups at highest risk for HIV infection, with a prevalence of 27·7% in the USA; and despite this known high risk, undiagnosed infection is common in this population. We set out to identify transgender women and their partners in a molecular transmission network to prioritise public health activities. METHODS: Since 2006, HIV protease and reverse transcriptase gene (pol) sequences from drug resistance testing have been reported to the Los Angeles County Department of Public Health and linked to demographic data, gender, and HIV transmission risk factor data for each case in the enhanced HIV/AIDS Reporting System. We reconstructed a molecular transmission network by use of HIV-TRAnsmission Cluster Engine (with a pairwise genetic distance threshold of 0·015 substitutions per site) from the earliest pol sequences from 22 398 unique individuals, including 412 (2%) self-identified transgender women. We examined the possible predictors of clustering with multivariate logistic regression. We characterised the genetically linked partners of transgender women and calculated assortativity (the tendency for people to link to other people with the same attributes) for each transmission risk group. FINDINGS: 8133 (36·3%) of 22 398 individuals clustered in the network across 1722 molecular transmission clusters. Transgender women who indicated a sexual risk factor clustered at the highest frequency in the network, with 147 (43%) of 345 being linked to at least one other person (adjusted odds ratio [aOR] 2·0, p=0·0002). Transgender women were assortative in the network (assortativity 0·06, p<0·001), indicating that they tended to link to other transgender women. Transgender women were more likely than expected to link to other transgender women (OR 4·65, p<0·001) and cisgender men who did not identify as men who have sex with men (MSM; OR 1·53, p<0·001). Transgender women were less likely than expected to link to MSM (OR 0·75, p<0·001), despite the high prevalence of HIV among MSM. Transgender women were distributed across 126 clusters, and cisgender individuals linked to one transgender woman were 9·2 times more likely to link to a second transgender woman than other individuals in the surveillance database. Reconstruction of the transmission network is limited by sample availability, but sequences were available for more than 40% of diagnoses. INTERPRETATION: Clustering of transgender women and the observed tendency for linkage with cisgender men who did not identify as MSM, shows the potential to use molecular epidemiology both to identify clusters that are likely to include undiagnosed transgender women with HIV and to improve the targeting of public health prevention and treatment services to transgender women. FUNDING: California HIV and AIDS Research Program and National Institutes of Health-National Institute of Allergy and Infectious Diseases.
Authors: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Hansjakob Furrer; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; Bruno Ledergerber; Sebastian Bonhoeffer; Huldrych F Günthard Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: Jeffrey H Herbst; Elizabeth D Jacobs; Teresa J Finlayson; Vel S McKleroy; Mary Spink Neumann; Nicole Crepaz Journal: AIDS Behav Date: 2007-08-13
Authors: Joel O Wertheim; Sergei L Kosakovsky Pond; Lisa A Forgione; Sanjay R Mehta; Ben Murrell; Sharmila Shah; Davey M Smith; Konrad Scheffler; Lucia V Torian Journal: PLoS Pathog Date: 2017-01-09 Impact factor: 6.823
Authors: Bryan T Grenfell; Oliver G Pybus; Julia R Gog; James L N Wood; Janet M Daly; Jenny A Mumford; Edward C Holmes Journal: Science Date: 2004-01-16 Impact factor: 47.728
Authors: Stéphane Hué; Alison E Brown; Manon Ragonnet-Cronin; Samantha J Lycett; David T Dunn; Esther Fearnhill; David I Dolling; Anton Pozniak; Deenan Pillay; Valerie C Delpech; Andrew J Leigh Brown Journal: AIDS Date: 2014-08-24 Impact factor: 4.177
Authors: Erik M Volz; James S Koopman; Melissa J Ward; Andrew Leigh Brown; Simon D W Frost Journal: PLoS Comput Biol Date: 2012-06-28 Impact factor: 4.475
Authors: Jessica E Long; Michalina Montaño; Hugo Sanchez; Leyla Huerta; Dania Calderón Garcia; Javier R Lama; Michele Andrasik; Ann Duerr Journal: Arch Sex Behav Date: 2021-10-06
Authors: Adiba Hassan; Victor De Gruttola; Yunyin W Hu; Zhijuan Sheng; Kathleen Poortinga; Joel O Wertheim Journal: Clin Infect Dis Date: 2020-12-03 Impact factor: 9.079
Authors: Manon Ragonnet-Cronin; Nanette Benbow; Christina Hayford; Kathleen Poortinga; Fangchao Ma; Lisa A Forgione; Zhijuan Sheng; Yunyin W Hu; Lucia V Torian; Joel O Wertheim Journal: AIDS Res Hum Retroviruses Date: 2021-02-08 Impact factor: 1.723
Authors: Margarita Matías-Florentino; Antoine Chaillon; Santiago Ávila-Ríos; Sanjay R Mehta; Héctor E Paz-Juárez; Manuel A Becerril-Rodríguez; Silvia J Del Arenal-Sánchez; Alicia Piñeirúa-Menéndez; Verónica Ruiz; Patricia Iracheta-Hernández; Israel Macías-González; Jehovani Tena-Sánchez; Florentino Badial-Hernández; Andrea González-Rodríguez; Gustavo Reyes-Terán Journal: J Antimicrob Chemother Date: 2020-03-01 Impact factor: 5.790
Authors: Andrea L Wirtz; Tonia Poteat; Asa Radix; Keri N Althoff; Christopher M Cannon; Andrew J Wawrzyniak; Erin Cooney; Kenneth H Mayer; Chris Beyrer; Allan E Rodriguez; Sari L Reisner Journal: JMIR Res Protoc Date: 2019-10-03